Torrey Pines Institute For Molecular Studies

Torrey Pines Institute For Molecular Studies

Torrey Pines Institute for Molecular Studies, also commonly referred to as TPIMS, is a non-profit biomedical research institute "dedicated to the discovery of causes, treatments and cures for a wide variety of diseases and afflictions including heart disease, cancer, AIDS, diabetes, multiple sclerosis, Alzheimer's, aging-relating conditions, and pain management. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Torrey Pines Institute For Molecular Studies, United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

52%


Total
Publications

2K


Total Open
Publications

1.1K


Total
Citations

136K


Open Access
Percentage

52%


Total
Publications

2K


Total Open
Publications

1.1K


Total
Citations

136K

Wikipedia

Website

download

Breakdown

11% 22% 19% 48%

Publisher Open

11%

Both

22%

Other Platform Open

19%

Closed

48%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110120130140Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

182

Hybrid 33%

215

No Guarantees 40%

263

Other Platform Open

Domain 88%

735

Institution 14%

113

Public 10%

87

Other Internet 7%

60

Preprint 6%

47

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
733
Europe PMC
Domain
566
Semantic Scholar
Public
68
Figshare
Public
33
DOI
Other Internet
31
bioRxiv
Preprint
29
University of California - eScholarship University of California
Institution
15
California Digital Library - eScholarship
Other Internet
13
CiteSeer X
Other Internet
12
Unknown Repository
Other Internet
10
1 / 10

Data updated 7 October 2024

Share

Share

Share